Decrease (-) Restore Default Increase (+)

Clinical Trials

Topic   Pulmonary
Title   A Randomized, Double-blind, Double Dummy, Chronic Dosing (56 week) Placebo-controlled, Parallel Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of 3 Doses of Benralizumab (MEDI-563) in Patients with Moderate to Very Severe Chronic
Summary   COPD - Patients diagnosed with having COPD are being asked to participate in this clinical research study.
Description   NYU Winthrop Hospital Clinical Research Center is conducting this clinical trial for patients between the ages of 40 and 85 years and old, who have been diagnosed with COPD. COPD causes symptoms such as shortness of breath, wheezing and frequent cough.

Eligible participants will receive study-related medical examinations, health monitoring, research medication and laboratory tests at no cost, while they are participating in this clinical research study. Compensation may be provided for your travel.
For more information please contact:

NYU Winthrop Hospital
Clinical Research Center
101 Mineola Blvd., Suite 3-002
Mineola, NY 11501
Telephone: 516-663-9582
Fax: 516-663-9587
Email: clinicaltrials@nyuwinthrop.org
IRB Number   -
Inclusion/Notes   To be eligible for this clinical research study you must:

• Be between the ages of 40 and 85 years old
• Be diagnosed with COPD, emphysema, or chronic bronchitis
• A current or former smoker
• Use oxygen less than 15 hours per day
Principal Name   Jonathan Ilowite, MD
Email   clinicaltrials@nyuwinthrop.org
Fax   516-663-9587
Phone   516-663-9582